Literature DB >> 15195095

Dopamine depletion impairs precursor cell proliferation in Parkinson disease.

Günter U Höglinger1, Pamela Rizk, Marie P Muriel, Charles Duyckaerts, Wolfgang H Oertel, Isabelle Caille, Etienne C Hirsch.   

Abstract

Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195095     DOI: 10.1038/nn1265

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  282 in total

1.  Adult human neurogenesis: from microscopy to magnetic resonance imaging.

Authors:  Amanda Sierra; Juan M Encinas; Mirjana Maletic-Savatic
Journal:  Front Neurosci       Date:  2011-04-04       Impact factor: 4.677

2.  No evidence for new dopaminergic neurons in the adult mammalian substantia nigra.

Authors:  Helena Frielingsdorf; Katherine Schwarz; Patrik Brundin; Paul Mohapel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

3.  Aging of the subventricular zone neural stem cell niche.

Authors:  Joanne C Conover; Brett A Shook
Journal:  Aging Dis       Date:  2011-09-20       Impact factor: 6.745

Review 4.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

Review 5.  In Vitro Models for Neurogenesis.

Authors:  Hassan Azari; Brent A Reynolds
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

Review 6.  Activity Dependency and Aging in the Regulation of Adult Neurogenesis.

Authors:  Gerd Kempermann
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-11-02       Impact factor: 10.005

7.  Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.

Authors:  Emrin Horgusluoglu; Kelly Nudelman; Kwangsik Nho; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-16       Impact factor: 3.568

8.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

9.  Dopaminergic innervation of the human subventricular zone: a comparison between Huntington's chorea and Parkinson's disease.

Authors:  Martin Parent; C Bédard; E Pourcher
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

10.  Adult neurogenesis is functionally associated with AD-like neurodegeneration.

Authors:  Qian Chen; Akira Nakajima; Se Hoon Choi; Xiaoli Xiong; Sangram S Sisodia; Ya-Ping Tang
Journal:  Neurobiol Dis       Date:  2007-11-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.